Management of diabetes mellitus in chronic kidney disease

被引:39
作者
Garla, Vishnu [1 ]
Kanduri, Swetha [1 ]
Yanes-Cardozo, Licy [1 ]
Lien, Lillian F. [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Endocrinol Diabet & Metab Internal Med, 2500 North State St, Jackson, MS 39216 USA
关键词
Diabetes mellitus; Renal insufficiency; chronic; Hypoglycemia; Peritoneal dialysis; CLINICAL-PRACTICE GUIDELINE; PERITONEAL-DIALYSIS; CARDIOVASCULAR OUTCOMES; RENAL-TRANSPLANTATION; GLUCOSE-HOMEOSTASIS; SGLT2; INHIBITORS; GLYCATED ALBUMIN; GLYCEMIC CONTROL; RISK-FACTORS; BETA-CELLS;
D O I
10.23736/S0391-1977.19.03015-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) and chronic kidney disease (CKD) are two chronic diseases whose prevalence and coprevalence arc on the rise. CKD is also the most debilitating and expensive complication of DM while management of DM in CKD is most challenging. CKD is developing in much younger patients with DM, and its presentation is also changing. Various methods of glycemic assessment are affected by CKD and dosage of DM medications needs to be adjusted according to the kidney function. One of the significant barriers to glycemic control in DM patients with CKD is hypoglycemia; close monitoring of glucose levels is essential. Dialysis affects the glucose homeostasis and insulin pharmacokinetics; therefore diabetic medication regimen needs to be adjusted accordingly. Kidney transplants are being increasingly performed as an alternative to dialysis. With the increased survival of transplants secondary to improved immunosuppressive regimen, the prevalence of post-transplant diabetes mellitus is on the increase. Good glycemic control is necessary for the survival of the transplant.
引用
收藏
页码:273 / 287
页数:15
相关论文
共 89 条
[1]   Haemodialysis-induced hypoglycaemia and glycaemic disarrays (vol 11, pg 302, 2015) [J].
Abe, Masanori ;
Kalantar-Zadeh, Kamyar .
NATURE REVIEWS NEPHROLOGY, 2015, 11 (05) :I-I
[2]   Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice [J].
Abe, Masanori ;
Okada, Kazuyoshi ;
Soma, Masayoshi .
CURRENT DRUG METABOLISM, 2011, 12 (01) :57-69
[3]   Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus [J].
Alsahli, Mazen ;
Gerich, John E. .
MAYO CLINIC PROCEEDINGS, 2014, 89 (11) :1564-1571
[4]   Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019 [J].
Cefalu, William T. ;
Berg, Erika Gebel ;
Saraco, Mindy ;
Petersen, Matthew P. ;
Uelmen, Sacha ;
Robinson, Shamera .
DIABETES CARE, 2019, 42 :S13-S28
[5]  
[Anonymous], 2013, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States
[6]  
[Anonymous], 2014, IDF DIAB ATL UPD POS
[7]   Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease [J].
Apel, Jill ;
Reutrakul, Sirimon ;
Baldwin, David .
CLINICAL KIDNEY JOURNAL, 2014, 7 (03) :248-250
[8]   Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial [J].
Bahar, Adele ;
Kashi, Zahra ;
Daneshpour, Ezzatossadat ;
Akha, Ozra ;
Ala, Shahram .
MEDICINE, 2016, 95 (40)
[9]  
Barnard K, 2011, GLYCEMIC CONTROL IN THE HOSPITALIZED PATIENT: A COMPREHENSIVE CLINICAL GUIDE, P7, DOI 10.1007/978-1-60761-006-9_2
[10]   Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140-2147 [J].
Bergenstal, Richard M. ;
Rosenstock, Julio ;
Arakaki, Richard F. ;
Prince, Melvin J. ;
Qu, Yongming ;
Sinha, Vikram P. ;
Howey, Daniel C. ;
Jacober, Scott J. .
DIABETES CARE, 2013, 36 (07) :E107-+